-
Protease Inhibitor Control of Light-Induced Stomatal Opening
2026-07-13
This study identifies novel roles for specific protease inhibitors in modulating blue light-induced stomatal opening, revealing their action downstream of photoreceptor activation but upstream of H+-ATPase phosphorylation. The findings advance understanding of guard cell signaling and offer robust chemical tools for dissecting plant physiological pathways.
-
Weight Loss Restores Intestinal Stretch Control of Satiety a
2026-07-13
This study reveals that intestinal stretch acutely suppresses food intake and improves glucose tolerance, but these effects are blunted in obesity. Both dietary and surgical weight loss fully restore stretch-induced satiety and metabolic responses, offering new insight into non-hormonal mechanisms of appetite regulation and type II diabetes research.
-
Standardized Amplex Red Assay Advances Autotaxin Inhibitor S
2026-07-12
Stylianaki et al. present a robust, fluorometry-based Amplex Red assay protocol for quantifying autotaxin (ATX) inhibitor efficacy. This standardized approach streamlines hit identification, IC50 determination, and mode-of-inhibition analysis—offering high reproducibility and scalability for preclinical drug discovery.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Protocol and QC Gui
2026-07-10
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides sensitive, fluorescence-based detection of rabbit primary antibodies in immunofluorescence, immunohistochemistry, and flow cytometry. This reagent is ideal for signal amplification in immunoassays where robust and specific detection is critical. It is not suited for diagnostic or clinical applications, nor for use with non-rabbit primary antibodies.
-
Dynasore: Precision Dynamin GTPase Inhibition for Endocytosi
2026-07-09
Dynasore empowers researchers with robust, reversible inhibition of dynamin-dependent endocytosis, enabling high-resolution dissection of vesicle trafficking and pathogen entry mechanisms. Its application in advanced cellular models, such as Drosophila S2 cells, opens new avenues for studying host-pathogen interactions and signaling pathways with exceptional reproducibility.
-
LNP-NamiRNA Dual Pathway Suppression of Pancreatic Cancer Gr
2026-07-09
Yu et al. reveal that LNP-delivered mir-200c NamiRNA can suppress pancreatic cancer proliferation and migration through two distinct mechanisms: enhancer-mediated activation of PTPN6 and post-transcriptional repression of CDH17. These findings provide a mechanistic blueprint for RNA-based therapeutic strategies and highlight robust experimental approaches for cell proliferation analysis.
-
Bradykinin in Translational Vascular Research: Mechanism, As
2026-07-08
Explore how Bradykinin, a potent endothelium-dependent vasodilator, advances vascular and inflammation research. This article uniquely connects molecular mechanism, assay design, and the latest mitochondrial pathway discoveries for deeper, more reproducible insights.
-
Streptavidin – Cy5: Precision Biotin Detection in Oncology
2026-07-08
Streptavidin – Cy5 combines exceptional biotin affinity with Cy5’s bright, far-red fluorescence for robust, multiplexed detection in cancer research. Its reliability in flow cytometry, immunohistochemistry, and in situ hybridization makes it a cornerstone for sensitive pathway analysis and apoptosis studies.
-
Efficient Purification of Recombinant Annexin V for Biophysi
2026-07-07
This article examines a streamlined method for purifying recombinant annexin V as described by Burger et al. The protocol’s main innovation lies in the gentle disruption of E. coli cells and calcium-mediated affinity steps, enabling high-purity protein suitable for advanced biophysical analyses.
-
U 46619: Mechanism, Benchmarks, and Protocols in Platelet Re
2026-07-07
U 46619 (11,9 epoxymethano-prostaglandin H2) is a selective agonist of thromboxane and prostaglandin H2 receptors, widely used as a platelet aggregation inducer. This article summarizes its mechanistic action, quantitative benchmarks, and protocol integration, and clarifies boundaries for translational use.
-
Adiponectin Mitigates Surgery-Induced Cognitive Deficits in
2026-07-06
This study reveals that adiponectin treatment significantly attenuates cognitive impairment following splenectomy in aged rats by suppressing neuroinflammation and oxidative stress via the TLR4/MyD88/NF-κB pathway. The findings highlight the therapeutic potential of targeting innate immune signaling in perioperative neurocognitive disorder (PND).
-
SR 11302: AP-1 Transcription Factor Inhibitor in Cancer Rese
2026-07-06
SR 11302 enables precise inhibition of AP-1-driven oncogenic pathways while minimizing off-target effects typical of retinoids, making it a powerful tool for dissecting tumor promotion and immune modulation in cancer models. Leveraging robust selectivity and workflow adaptability, this agent empowers translational and preclinical research in chemoprevention and therapy.
-
3-Deazaadenosine Hydrochloride: Selective SAHH Inhibition fo
2026-07-05
3-Deazaadenosine hydrochloride is a potent S-adenosylhomocysteine hydrolase inhibitor used to dissect methylation-driven mechanisms in inflammation and fibrosis. Its high purity and solubility support reproducible workflows in hepatic stellate cell studies, enabling targeted analysis of cell proliferation and methyltransferase-dependent pathways.
-
Atrial Natriuretic Peptide (ANP): Integrative Roles in Cardi
2026-07-04
Explore the multifaceted actions of Atrial Natriuretic Peptide (ANP) peptide hormone, its mechanistic depth in cardiovascular and neuroinflammatory pathways, and how cutting-edge assay design leverages ANP’s unique properties beyond standard workflow protocols.
-
Bradykinin: Technical Guidance for Vasodilation & Permeabili
2026-07-03
Bradykinin (SKU BA5201) is a research-grade endothelium-dependent vasodilator peptide designed for experimental protocols requiring precise modulation of vascular tone, permeability, and smooth muscle contraction. This product is not intended for diagnostic or clinical applications and should be reserved for in vitro or ex vivo research where protocol control and purity are essential.